Zhou C - Search Results

1

Stage-specific embryonic antigen 4 expression in epithelial ovarian carcinoma.

Ye F, Li Y, Hu Y, Zhou C, Hu Y, Chen H. Ye F, et al. Among authors: zhou c. Int J Gynecol Cancer. 2010 Aug;20(6):958-64. doi: 10.1111/IGC.0b013e3181e6fee1. Int J Gynecol Cancer. 2010. PMID: 20683402

2

[Establishment of methotrexate-resistant human choriocarcinoma cell line and its biological characteristics].

Chen YX, Xia X, Chen HZ, Cheng Q, Zhou CY. Chen YX, et al. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2004 Mar;33(2):138-42, 165. doi: 10.3785/j.issn.1008-9292.2004.02.011. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2004. PMID: 15067735 Chinese.

3

[Tumor lymphangiogenesis in cervical squamous cell carcinoma and its clinical significance].

Zhang JP, Lü WG, Chen HZ, Zhou CY, Xie X. Zhang JP, et al. Zhonghua Yi Xue Za Zhi. 2005 Jun 15;85(22):1551-4. Zhonghua Yi Xue Za Zhi. 2005. PMID: 16179117 Chinese.

4

Altered expression of cellular membrane molecules of HLA-DR, HLA-G and CD99 in cervical intraepithelial neoplasias and invasive squamous cell carcinoma.

Zhou JH, Ye F, Chen HZ, Zhou CY, Lu WG, Xie X. Zhou JH, et al. Life Sci. 2006 Apr 25;78(22):2643-9. doi: 10.1016/j.lfs.2005.10.039. Epub 2006 Jan 24. Life Sci. 2006. PMID: 16434060

5

[Expression and clinical significance of Beclin1 and PTEN in endometrial carcinoma].

Zhao JH, Wan XY, Xie X, Zhou CY, Wu QY. Zhao JH, et al. Ai Zheng. 2006 Jun;25(6):753-7. Ai Zheng. 2006. PMID: 16764775 Chinese.

6

Stem-cell-abundant proteins Nanog, Nucleostemin and Musashi1 are highly expressed in malignant cervical epithelial cells.

Ye F, Zhou C, Cheng Q, Shen J, Chen H. Ye F, et al. Among authors: zhou c. BMC Cancer. 2008 Apr 18;8:108. doi: 10.1186/1471-2407-8-108. BMC Cancer. 2008. PMID: 18419830 Free PMC article.

7

Expression of Sox2 in human ovarian epithelial carcinoma.

Ye F, Li Y, Hu Y, Zhou C, Hu Y, Chen H. Ye F, et al. Among authors: zhou c. J Cancer Res Clin Oncol. 2011 Jan;137(1):131-7. doi: 10.1007/s00432-010-0867-y. Epub 2010 Mar 27. J Cancer Res Clin Oncol. 2011. PMID: 20349085

8

Identification of glia maturation factor beta as an independent prognostic predictor for serous ovarian cancer.

Li YL, Ye F, Cheng XD, Hu Y, Zhou CY, Lü WG, Xie X. Li YL, et al. Eur J Cancer. 2010 Jul;46(11):2104-18. doi: 10.1016/j.ejca.2010.04.015. Epub 2010 May 22. Eur J Cancer. 2010. PMID: 20547056

9

Expression of octamer-4 in serous and mucinous ovarian carcinoma.

Zhang J, Li YL, Zhou CY, Hu YT, Chen HZ. Zhang J, et al. J Clin Pathol. 2010 Oct;63(10):879-83. doi: 10.1136/jcp.2009.073593. J Clin Pathol. 2010. PMID: 20876318

10

Significance of PTPRZ1 and CIN85 expression in cervical carcinoma.

Ma Y, Ye F, Xie X, Zhou C, Lu W. Ma Y, et al. Among authors: zhou c. Arch Gynecol Obstet. 2011 Sep;284(3):699-704. doi: 10.1007/s00404-010-1693-9. Epub 2010 Sep 30. Arch Gynecol Obstet. 2011. PMID: 20882291

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21,154 results

Search Page

Filters